Search Articles

View query in Help articles search

Search Results (1 to 1 of 1 Results)

Download search results: CSV END BibTex RIS


Novel Interactive Tool for Breast and Ovarian Cancer Risk Assessment (Bright Pink Assess Your Risk): Development and Usability Study

Novel Interactive Tool for Breast and Ovarian Cancer Risk Assessment (Bright Pink Assess Your Risk): Development and Usability Study

Moreover, among those with a strong family history of breast or ovarian cancer, but who have not received genetic testing, an estimated 20% to 30% have a pathogenic mutation in a breast cancer susceptibility gene [10]. Bright Pink is a nonprofit organization devoted to improving breast and ovarian cancer prevention through the belief that empowering educated patients leads to (1) lower distress associated with cancer risk assessment and (2) improved cancer prevention outcomes [18,19].

Elizabeth A Anne Hibler, Angela J Fought, Kiarri N Kershaw, Rebecca Molsberry, Virginia Nowakowski, Deborah Lindner

J Med Internet Res 2022;24(2):e29124